1. Home
  2. CHRO vs LSH Comparison

CHRO vs LSH Comparison

Compare CHRO & LSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHRO
  • LSH
  • Stock Information
  • Founded
  • CHRO 2002
  • LSH 2018
  • Country
  • CHRO United States
  • LSH United States
  • Employees
  • CHRO N/A
  • LSH N/A
  • Industry
  • CHRO
  • LSH
  • Sector
  • CHRO
  • LSH
  • Exchange
  • CHRO Nasdaq
  • LSH NYSE
  • Market Cap
  • CHRO 8.4M
  • LSH 7.3M
  • IPO Year
  • CHRO 2024
  • LSH 2024
  • Fundamental
  • Price
  • CHRO $1.14
  • LSH $0.93
  • Analyst Decision
  • CHRO Strong Buy
  • LSH
  • Analyst Count
  • CHRO 1
  • LSH 0
  • Target Price
  • CHRO N/A
  • LSH N/A
  • AVG Volume (30 Days)
  • CHRO 83.2K
  • LSH 47.7K
  • Earning Date
  • CHRO 05-13-2025
  • LSH 08-01-2025
  • Dividend Yield
  • CHRO N/A
  • LSH N/A
  • EPS Growth
  • CHRO N/A
  • LSH N/A
  • EPS
  • CHRO N/A
  • LSH N/A
  • Revenue
  • CHRO N/A
  • LSH $16,270,095.00
  • Revenue This Year
  • CHRO N/A
  • LSH N/A
  • Revenue Next Year
  • CHRO N/A
  • LSH N/A
  • P/E Ratio
  • CHRO N/A
  • LSH N/A
  • Revenue Growth
  • CHRO N/A
  • LSH N/A
  • 52 Week Low
  • CHRO $0.45
  • LSH $0.84
  • 52 Week High
  • CHRO $3.80
  • LSH $5.37
  • Technical
  • Relative Strength Index (RSI)
  • CHRO 53.88
  • LSH N/A
  • Support Level
  • CHRO $0.90
  • LSH N/A
  • Resistance Level
  • CHRO $1.06
  • LSH N/A
  • Average True Range (ATR)
  • CHRO 0.09
  • LSH 0.00
  • MACD
  • CHRO 0.03
  • LSH 0.00
  • Stochastic Oscillator
  • CHRO 95.88
  • LSH 0.00

About CHRO Chromocell Therapeutics Corporation

Channel Therapeutics Corp is a clinical-stage biotechnology company developing and commercializing novel, non-opioid, non-addictive therapeutics to alleviate pain. The initial clinical focus is to selectively target the sodium ion channel known as NaV1.7 for the treatment of various types of chronic, visceral pain, acute and chronic eye pain, and post-surgical nerve blocks. Its pipeline includes CC8464 for ISFN and EM and CT2000 for Acute and CHronic Eye Pain-Dry Eye Disease.

About LSH LAKESIDE HOLDING LTD

Lakeside Holding Ltd i an integrated cross-border supply chain solution provider with a strategic focus on the Asian market including China and South Korea. It provides customized cross-border ocean freight solutions and airfreight solutions in the U.S, including cross-border freight consolidation and forwarding services; customs clearance services; warehousing and distribution services and U.S. domestic ground transportation services.

Share on Social Networks: